David K. Miyamoto

620 total citations
9 papers, 406 citations indexed

About

David K. Miyamoto is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, David K. Miyamoto has authored 9 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Hematology and 2 papers in Organic Chemistry. Recurrent topics in David K. Miyamoto's work include Protein Degradation and Inhibitors (4 papers), Acute Myeloid Leukemia Research (2 papers) and Click Chemistry and Applications (2 papers). David K. Miyamoto is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), Acute Myeloid Leukemia Research (2 papers) and Click Chemistry and Applications (2 papers). David K. Miyamoto collaborates with scholars based in United States. David K. Miyamoto's co-authors include Daniel K. Nomura, Tucker R. Huffman, Leslie A. Bateman, Christine F. Skibola, Carl C. Ward, Jessica N. Spradlin, Eranthie Weerapana, Lisa A. Crawford, Carlo M. Contreras and Roman Camarda and has published in prestigious journals such as Blood, Cancer Cell and Chemical Communications.

In The Last Decade

David K. Miyamoto

9 papers receiving 402 citations

Peers

Countries citing papers authored by David K. Miyamoto

Since Specialization

Citations

This map shows the geographic impact of David K. Miyamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David K. Miyamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David K. Miyamoto more than expected).

Fields of papers citing papers by David K. Miyamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David K. Miyamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David K. Miyamoto. The network helps show where David K. Miyamoto may publish in the future.

Co-authorship network of co-authors of David K. Miyamoto

This figure shows the co-authorship network connecting the top 25 collaborators of David K. Miyamoto. A scholar is included among the top collaborators of David K. Miyamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David K. Miyamoto. David K. Miyamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Design and Development of IKZF2 and CK1α Dual Degraders 2023 ·Journal of Medicinal Chemistry ·David K. Miyamoto, (unknown), Sun‐Mi Park, (unknown), Michael G. Kharas, Christina M. Woo	13
2	Dual IKZF2 and CK1α degrader targets acute myeloid leukemia cells 2023 ·Cancer Cell ·Sun‐Mi Park, David K. Miyamoto, (unknown), (unknown), (unknown), (unknown), (unknown), Jun Hyun Kim, Alexandra Schurer, (unknown), (unknown), Michael G. Kharas, Christina M. Woo	23
3	Dual IKZF2 and CK1α Degrader Targets Acute Myeloid Leukemia Cells 2022 ·Blood ·Sun Mi Park, David K. Miyamoto, (unknown), (unknown), (unknown), (unknown), (unknown), Jun Hyun Kim, Alexandra Schurer, (unknown), Christina M. Woo, Michael G. Kharas	3
4	Small Molecule Interactome Mapping by Photo‐Affinity Labeling (SIM‐PAL) to Identify Binding Sites of Small Molecules on a Proteome‐Wide Scale 2019 ·PubMed ·Hope A. Flaxman, David K. Miyamoto, Christina M. Woo	17
5	Chemoproteomics-enabled covalent ligand screen reveals a cysteine hotspot in reticulon 4 that impairs ER morphology and cancer pathogenicity 2017 ·Chemical Communications ·Leslie A. Bateman, Truc Nguyen, Allison M. Roberts, David K. Miyamoto, (unknown), Tucker R. Huffman, Yana Petri, Marty J. Heslin, Carlo M. Contreras, Christine F. Skibola, James A. Olzmann, Daniel K. Nomura	59
6	Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural Products 2017 ·Cell chemical biology ·(unknown), Carl C. Ward, Jessica N. Spradlin, Leslie A. Bateman, Tucker R. Huffman, David K. Miyamoto, (unknown), Daniel K. Nomura	92
7	Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target 2017 ·ACS Chemical Biology ·Allison M. Roberts, David K. Miyamoto, Tucker R. Huffman, Leslie A. Bateman, Ashley N. Ives, David Akopian, Martin J. Heslin, Carlo M. Contreras, Michael Rapé, Christine F. Skibola, Daniel K. Nomura	76
8	GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity 2016 ·Cell chemical biology ·Sharon M. Louie, (unknown), Lisa A. Crawford, (unknown), Roman Camarda, Tucker R. Huffman, David K. Miyamoto, Andrei Goga, Eranthie Weerapana, Daniel K. Nomura	115
9	Chemical Genetics Screening Reveals KIAA1363 as a Cytokine-Lowering Target 2014 ·ACS Chemical Biology ·Devon M. Hunerdosse, Patrick J. Morris, David K. Miyamoto, Karl J. Fisher, Leslie A. Bateman, (unknown), (unknown), Daniel K. Nomura	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact